BONUSCAP-ZERTIFIKAT - PFIZER INC Stock

Certificat

DE000HD41NM6

Market Closed - Boerse Frankfurt Warrants 01:27:48 2024-06-20 pm EDT
34.82 EUR +1.04% Intraday chart for BONUSCAP-ZERTIFIKAT - PFIZER INC
Current month+0.61%
1 month+0.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-20 34.82 +1.04%
24-06-19 34.46 +0.06%
24-06-18 34.44 +0.85%
24-06-17 34.15 -0.93%
24-06-14 34.47 -0.38%

Real-time Boerse Frankfurt Warrants

Last update June 20, 2024 at 01:27 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD41NM
ISINDE000HD41NM6
Date issued 2024-03-22
Strike 37 $
Maturity 2025-03-21 (274 Days)
Parity 1 : 1
Emission price 34.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 35.07
Lowest since issue 31.2
Spread 0.01
Spread %0.03%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.74 USD
Average target price
31.92 USD
Spread / Average Target
+15.05%
Consensus